International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Tóm tắt
Từ khóa
Tài liệu tham khảo
Barragan, 1999, Neural contribution to the effect of glucagon-like peptide-1-(7–36) amide on arterial blood pressure in rats., Am J Physiol, 277, E784
Bataille D (1996a) Oxyntomodulin and its related peptides. in Glucagon III, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 327–340.
Bataille D (1996b) Preproglucagon and its processing. in Glucagon III, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 31–51.
Baum, 1962, Localization of glucagon in the alpha cells in the pancreatic islet by immunofluorescent techniques., Diabetes, 11, 371
Baumann, 1997, The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene., Acta Paediatr Suppl, 423, 33, 10.1111/j.1651-2227.1997.tb18366.x
Bayliss, 1902, On the causation of the so-called “peripheral reflex secretion” of the pancreas., Proc R Soc Lond Biol, 69, 352, 10.1098/rspl.1901.0119
Benjamin MA McKay DM Yang PC Cameron H Perdue MH (2000) Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 47:112–119.
Boushey, 1999, Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis., Am J Physiol, 277, E937
Boushey, 2001, Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor., Cancer Res, 61, 687
Brown JC (1982) Gastric inhibitory polypeptide. Monographs in Endocrinology (Springer-Verlag, Heidelberg).
Brubaker, 1997, Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2., Am J Physiol, 272, E1050
Buhl, 1988, Naturally occurring products of proglucagon 111–160 in the porcine and human small intestine., J Biol Chem, 263, 8621, 10.1016/S0021-9258(18)68350-4
Campbell, 1992, Evolution of the growth hormone-releasing factor (GRF) family of peptides., Growth Regul, 2, 175
Canonico, 1983, Human pancreatic GRF stimulates phosphatidylinositol labeling in cultured anterior pituitary cells., Am J Physiol, 245, E587
Carruthers, 1994, Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding., J Biol Chem, 269, 29321, 10.1016/S0021-9258(19)62047-8
Chance, 1997, Prevention of parenteral nutrition-induced gut hyoplasia by coinfusion of glucagon-like peptide-2., Am J Physiol, 273, G559
Cheeseman, 1996, The effect of gastric inhibitory polypeptide and glucagon like peptides on intestinal hexose transport., Am J Physiol, 271, G477
Chiba, 1989, Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome., Gastroenterology, 96, 1439, 10.1016/0016-5085(89)90510-6
Christophe, 1996, Glucagon and its receptor in various tissues., Ann NY Acad Sci, 805, 31, 10.1111/j.1749-6632.1996.tb17471.x
Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N, and Sexton PM (2002) Novel receptor partners and function of receptor activity modifying proteins.J Biol Chem epub ahead of print.
Claus TH Park CR Pilkis SJ (1983) Glucagon and gluconeogenesis. in Glucagon I, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 315–360.
Coy, 1996, Structural simplification of potent growth hormone-releasing hormone analogs: implications for other members of the VIP/GHRH/PACAP family., Ann NY Acad Sci, 805, 149, 10.1111/j.1749-6632.1996.tb17480.x
Diamant B Picazo J (1983) Spasmolytic and clinical use of glucagon. in Glucagon II, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 611–643.
Ding, 2002, Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma., Cancer Res, 62, 5223
Dong, 2000, Dual contacts between peptide agonist ligands and the secretin receptor directly established by photoaffinity labeling., Ann NY Acad Sci, 921, 381, 10.1111/j.1749-6632.2000.tb07000.x
Drucker, 1988, Glucagon gene expression in vertebrate brain., J Biol Chem, 263, 13475, 10.1016/S0021-9258(18)68261-4
Drucker, 1999, Biologic properties and therapeutic potential of glucagon-like peptide-2., J Parenter Enteral Nutr, 23 (Suppl 5), S98, 10.1177/014860719902300524
Drucker, 1997, Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2., Am J Physiol, 273, G1252
Drucker, 1999, Human [Gly2]-GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis., Am J Physiol, 276, G79
Eaton RP (1977) Glucagon and lipoprotein regulation in man. in Glucagon: Its Role in Physiology and Clinical Medicine, eds Foa PP Bajaj JS Foa NL (Springer-Verlag, Berlin), p 553.
Ebert, 1987, Gastrointestinal peptides and insulin secretion., Diabetes Metab Rev, 3, 1, 10.1002/dmr.5610030101
Eicher, 1976, Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6., J Hered, 67, 87, 10.1093/oxfordjournals.jhered.a108682
Farah AE (1983) Glucagon and the heart. in Glucagon II, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 553–609.
Frohman, 1981, Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly., Prog Clin Biol Res, 74, 259
Gardner, 1976, Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells., Gastroenterology, 71, 965, 10.1016/S0016-5085(76)80043-1
Gaylinn, 1999, Molecular and cell biology of the growth hormone-releasing hormone receptor., Growth Horm IGF Res, 9 (Suppl A), 37, 10.1016/S1096-6374(99)80008-2
Goke, 1993, Exendin-4 is a high potency agonist and truncated exendin-(9–39)-amide an antagonist at the glucagon-like peptide 1-(7–36)-amide receptor of insulin-secreting β-cells., J Biol Chem, 268, 19650, 10.1016/S0021-9258(19)36565-2
Goke, 1989, Signal transmission after GLP-1(7–36)amide binding in RINm5F cells., Am J Physiol, 257, G397
Gros, 1992, Characterization of high affinity receptors for glucagon-like peptide-1 (7–36)amide on a somatostatin-secreting cell line., Biomed Res, 13, 143
Gutzwiller, 1999, Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2., Am J Physiol, 276, R1541
Haffar, 1991, Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists., J Biol Chem, 266, 316, 10.1016/S0021-9258(18)52437-6
Hansen, 2001, The growth hormone-releasing hormone receptor: desensitisation following short-term agonist exposure., Pharmacol Toxicol, 88, 81, 10.1034/j.1600-0773.2001.d01-87.x
Hansen, 1998, Glucagon-mediated Ca2+ signaling in BHK cells expressing cloned human glucagon receptors., Am J Physiol, 274, C1552, 10.1152/ajpcell.1998.274.6.C1552
Harmar, 2001, Family-B G-protein-coupled receptors., Genome Biol, 2, REVIEWS3013, 10.1186/gb-2001-2-12-reviews3013
Horikawa, 2002, [Isolated GH deficiency due to inactivating mutation of GHRH receptor]., Nippon Rinsho, 60, 297
Isenberg, 1972, Unusual effect of secretin on serum gastrin, serum calcium and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome., Gastroenterology, 62, 626, 10.1016/S0016-5085(72)80048-9
Ishihara, 1991, Molecular cloning and expression of a cDNA encoding the secretin receptor., EMBO (Eur Mol Biol Organ) J, 10, 1635, 10.1002/j.1460-2075.1991.tb07686.x
Iyengar, 1984, Structural analysis of the hepatic glucagon receptor. Identification of a guanine nucleotide-sensitive hormone-binding region., J Biol Chem, 259, 5222, 10.1016/S0021-9258(17)42978-4
Kubiak TM Friedman AR Moseley WM (1996) Synthetic analogs of growth hormone releasing factor (GHRF) with improved pharmaceutical properties. in Growth Hormone Secretagogues, eds Berc BB Walker RF (Springer Publishing, New York), pp 31–52.
Lasko, 2001, Differential GH-releasing hormone regulation of GHRH receptor mRNA expression in the rat pituitary., Am J Physiol Endocrinol Metab, 280, E626, 10.1152/ajpendo.2001.280.4.E626
Leiter AB Chey WY Kopin AS (1994) Secretin. in Gut Peptides: Biochemistry and Physiology, eds Walsh JH Dockray GJ (Raven Press, New York), pp 147–174.
Ling, 1984, Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor., Biochem Biophys Res Commun, 123, 854, 10.1016/0006-291X(84)90309-7
Lotersztajn, 1990, Glucagon-(19–29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins., J Biol Chem, 265, 9876, 10.1016/S0021-9258(19)38753-8
Lutz, 1993, Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cells., J Biol Chem, 268, 12136, 10.1016/S0021-9258(19)50318-0
Mayo, 1995, Growth hormone-releasing hormone: synthesis and signaling., Recent Prog Horm Res, 50, 35
Mayo, 2000, Regulation of the pituitary somatotroph cell by GHRH and its receptor., Recent Prog Horm Res, 55, 237
Mayo, 1996, The growth-hormone-releasing hormone receptor: signal transduction, gene expression and physiological function in growth regulation., Ann NY Acad Sci, 805, 184, 10.1111/j.1749-6632.1996.tb17483.x
Mentlein, 1993, Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum., Eur J Biochem, 214, 829, 10.1111/j.1432-1033.1993.tb17986.x
Merimee TJ (1983) Glucagon and growth hormone. in Glucagon II, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 545–551.
Mojsov, 1986, Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing., J Biol Chem, 261, 11880, 10.1016/S0021-9258(18)67324-7
Morris, 1996, Hypothesis: glucagon receptor glycine to serine missense mutation contributes to one in 20 cases of essential hypertension., Clin Exp Pharmacol Physiol, 23, 1035, 10.1111/j.1440-1681.1996.tb01164.x
Motomura, 1998, Inhibition of signal transduction by a splice variant of the growth hormone-releasing hormone receptor expressed in human pituitary adenomas., Metab Clin Exp, 47, 804, 10.1016/S0026-0495(98)90116-0
Mutt V (1980) Secretin: isolation, structure and functions. in Gastrointestinal Hormones, ed Glass GBJ (Raven Press, New York), pp 85–126.
O'Harte, 1999, NH2-terminally modified gastric inhibitory polypeptide exhibits amino- peptidase resistance and enhanced antihyperglycemic activity., Diabetes, 48, 758, 10.2337/diabetes.48.4.758
Ozcelebi, 1995, Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor., Mol Pharmacol, 48, 818
Park, 2000, Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation., J Pharmacol Exp Ther, 295, 682
Parker, 1998, Structure-function analysis of a series of glucagon-like peptide-1 analogs., J Pept Res, 52, 398, 10.1111/j.1399-3011.1998.tb00664.x
Rodbell, 1971, The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action., J Biol Chem, 246, 1877, 10.1016/S0021-9258(18)62390-7
Rodbell, 1971, The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity., J Biol Chem, 246, 1861, 10.1016/S0021-9258(18)62388-9
Sato, 1997, Gene regulation of growth hormone-releasing hormone and its receptor., Endocr J, 44, 765, 10.1507/endocrj.44.765
Schirra, 1997, Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility and pancreatic function in men., Proc Assoc Am Physicians, 109, 84
Schmidtler, 1994, Rat parietal cell receptors for GLP-1-(7–36) amide: Northern blot, cross-linking and radioligand binding., Am J Physiol, 267, G423
Scott, 1998, GLP-2 augments the adaptive response to massive intestinal resection in rat., Am J Physiol, 275, G911
Sivarajah, 2001, Evolution of receptors for proglucagon-derived peptides: isolation of frog glucagon receptors., Comp Biochem Physiol Part B Comp Biochem Mol Biol, 128, 517, 10.1016/S1096-4959(00)00355-9
Stalmans W (1983) Glucagon and liver glycogen metabolism. in Glucagon I, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 291–314.
Steinberg, 1959, Direct effect of glucagon on release of unesterified fatty acids (UFA) from adipose tissue., Clin Res, 7, 250
Stephanou, 1991, Production of a growth hormone-releasing hormone-like peptide and its mRNA by human lymphocytes., Neuroendocrinology, 53, 628
Sutherland, 1950, The effect of the hyperglycemic factor of the pancreas and of epinephrine on glycogenolysis., Recent Prog Horm Res, 5, 441
Thorens B Widmann C (1996) Structure and function of the glucagon-like peptide-1 receptor. in Handbook of Experimental Pharmacology Glucagon III, ed Lefebvre PJ (Springer-Verlag, Berlin), pp 255–273.
Thorner, 1982, Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor., J Clin Investig, 70, 965, 10.1172/JCI110708
Tsai, 1997, Intestinal growth-promoting properties of glucagon-like peptide 2 in mice., Am J Physiol, 273, E77
Tsai, 1997, Biological determinants of intestinotrophic properties of GLP-2 in vivo., Am J Physiol, 272, G662
Unson, 1991, Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding., J Biol Chem, 266, 2763, 10.1016/S0021-9258(18)49911-5
Vaudry, 2000, Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions., Pharmacol Rev, 52, 269
Xiao, 2000, Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease., Am J Physiol, 278, R1057
Yamato, 1997, Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1)., Horm Metab Res, 29, 56, 10.1055/s-2007-978985